News tagged with pharmaceutical
ACR: Strontium ranelate cuts progression of knee OA
(HealthDay)—The osteoporosis therapeutic strontium ranelate (SrRan) reduces radiographic and radiological progression of knee osteoarthritis, according to a study presented at the annual meeting of the ...
Arthritis & Rheumatism
Nov 12, 2012 |
not rated yet |
0
Italy lifts ban on Novartis flu vaccines
Italian health authorities on Friday lifted a ban on the sale of flu vaccines made by Swiss pharmaceutical giant Novartis, saying that tests had shown they were not a health risk.
Medications
Nov 09, 2012 |
not rated yet |
0
Canada high court voids Pfizer's Viagra patent
Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug.
Medications
Nov 08, 2012 |
not rated yet |
0
Statin use at cancer diagnosis linked to lower mortality
(HealthDay)—For patients with cancer, statin use prior to diagnosis correlates with reduced all-cause and cancer-related mortality, according to a study published in the Nov. 8 issue of the New England Jo ...
Cancer
Nov 08, 2012 |
3 / 5 (2) |
1
Xarelto's approval expanded
(HealthDay)—Approval of the anti-clotting drug Xarelto (rivaroxaban) has been expanded by the U.S. Food and Drug Administration to include treating deep vein thrombosis (DVT) or pulmonary embolism.
Medications
Nov 05, 2012 |
not rated yet |
0
Once-yearly zoledronic acid benefits men with osteoporosis
(HealthDay)—For men with osteoporosis, a once-yearly infusion with zoledronic acid is associated with fewer vertebral fractures and improved bone health compared with placebo, according to a study published ...
Diseases, Conditions, Syndromes
Nov 02, 2012 |
not rated yet |
0
Latrepirdine not effective in Huntington's disease
(HealthDay)—Although safe and well tolerated, the experimental small molecule latrepirdine does not improve cognition after six months of treatment in patients with mild-to-moderate Huntington's disease ...
Neuroscience
Nov 01, 2012 |
not rated yet |
0
Adverse prognostic factor ID'd in operable breast cancer
(HealthDay)—For women with operable breast cancer, moderate immunohistochemical expression of human epidermal growth factor receptor (HER)-2 (2+) without amplification of HER-2 (HER-2 2+/HER-2−) is an adverse prognostic ...
Cancer
Oct 30, 2012 |
not rated yet |
0
Insulin glargine's main metabolic effect as metabolite M1
(HealthDay)—For patients with type 2 diabetes, following administration of a subcutaneous injection of a therapeutic dose of insulin glargine, glargine is minimally detectable in blood, and most of the ...
Diabetes
Oct 25, 2012 |
not rated yet |
0
Experts call for increased neonatal inclusion in pediatric drug trials
Clinical drug trials are a vital part of pharmaceutical manufacturers gaining approval for use by the U.S. Food and Drug Administration. A Commentary scheduled for publication in The Journal of Pediatrics assesses the is ...
Pediatrics
Oct 25, 2012 |
not rated yet |
0
Hormonal changes at menopause up abdominal obesity
(HealthDay)—The increase in total body fat and abdominal fat seen at menopause is due to the hormonal changes taking place, which can be improved by estrogen treatment, according to a study published in ...
Overweight and Obesity
Oct 24, 2012 |
not rated yet |
0
|
Italy, Switzerland, Austria freeze sales of Novartis flu vaccines
Italian, Swiss and Austrian authorities on Wednesday halted the sale of flu vaccines made by Swiss pharmaceutical giant Novartis.
Medications
Oct 24, 2012 |
not rated yet |
0
Immune cells of the blood might replace dysfunctional brain cells
Blood-circulating immune cells can take over the essential immune surveillance of the brain, this is shown by scientists of the German Center for Neurodegenerative Diseases and the Hertie Institute for Clinical Brain Research ...
Medical research
Oct 22, 2012 |
not rated yet |
0
|
What we know and don't know about fungal meningitis outbreak
In a new perspective piece being published Online First tonight in Annals of Internal Medicine, a physician recalls lessons learned from treating patients affected by the 2002 outbreak of Exophiala (Wangiella) dermatitidis meningi ...
Diseases, Conditions, Syndromes
Oct 18, 2012 |
not rated yet |
0
New target for treating diabetic kidney disease, the leading cause of kidney failure
Researchers have discovered a new therapeutic target for diabetic nephropathy, the leading cause of kidney failure. The findings, appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) ...
Diseases, Conditions, Syndromes
Oct 18, 2012 |
5 / 5 (1) |
0
